• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD INC. (COVINGTON) -1018233 BARD® INLAY OPTIMA® URETERAL STENT WITH NICORE¿ GUIDEWIRE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD INC. (COVINGTON) -1018233 BARD® INLAY OPTIMA® URETERAL STENT WITH NICORE¿ GUIDEWIRE Back to Search Results
Catalog Number 786624
Medical Device Problem Code Material Fragmentation (1261)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 06/26/2025
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that, when the urethral stent package was opened during the operation and ready for placement, it was found that the drainage hole on the head of the ureteral stent was broken, and the stent had been replaced intraoperatively.
 
Additional Manufacturer Narrative
The investigation is still in progress.Once the investigation is complete a supplemental report will be filed.Udi format updated with available product information per gudid.H11: section a through f - the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event or Problem Description
It was reported that, when the urethral stent package was opened during the operation and ready for placement, it was found that the drainage hole on the head of the ureteral stent was broken, and the stent had been replaced intraoperatively.
 
Additional Manufacturer Narrative
The reported event was confirmed cause unknown.Visual evaluation noted received 3 photo samples.First two photo samples show non bd stent product.Third photo sample shows bd stent with pigtail end broken.Therefore, the reported event is confirmed.Instructions for use were reviewed for this investigation.The labelling was reviewed and found to be adequate.Dhr review did not show any problems or conditions that would have contributed to the reported event.Corrections: d, h.Udi format updated with available product information per gudid.H11: section a through f - the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BARD® INLAY OPTIMA® URETERAL STENT WITH NICORE¿ GUIDEWIRE
Common Device Name
URETERAL STENT
Manufacturer (Section D)
C.R. BARD INC. (COVINGTON) -1018233
8195 industrial blvd
covington GA 30014
Manufacturer (Section G)
C.R. BARD INC. (COVINGTON) -1018233
8195 industrial blvd
covington GA 30014
Manufacturer Contact
xeeroy rada
8195 industrial blvd
covington, GA 30014
7707846100
MDR Report Key22553994
Report Number1018233-2025-05974
Device Sequence Number21244354
Product Code FAD
UDI-Device Identifier10801741015110
UDI-Public(01)10801741015110(11)240221(17)280327(10)NGJN0442
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
K043193
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Other,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 11/05/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number786624
Device Lot NumberNGJN0442
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/26/2025
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/26/2025
Supplement Date Received by Manufacturer11/05/2025
Initial Report FDA Received Date07/21/2025
Supplement Report FDA Received Date11/13/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured02/21/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-